Insulet Corporation vs Abbvie Inc.
PODD vs ABBV — side-by-side comparison from reported financials. PODD leads 7, ABBV leads 4 of 11 comparable metrics.
Insulet Corporation
PODD · Healthcare
$135.28+0.60%Strong
Abbvie Inc.
ABBV · Healthcare
$276.43+1.47%Mixed
| Metric | PODD | ABBV |
|---|---|---|
| Price | $135.28 | $276.43 |
| Market cap | $9.38B | $488B |
| Revenue (TTM) | $3.05B | $64.4B |
| Revenue growth | +27.5% | +1.8% |
| Net margin | 12.3% | 9.8% |
| Free cash flow | $294M | $18.2B |
| Net cash (debt) | ($215M) | ($56.2B) |
| 1-year price return | -57.8% | +19.8% |
| P/E | 25.0 | 77.4 |
| P/E vs own history (cheap-side %) | 99% | 23% |
| Dividend yield | — | 2.45% |
| Return on equity | 17% | 96% |
| Altman Z-score | 4.61 | 2.33 |
| CV checks passed | 10 of 10 | 9 of 10 |
| Employees | 5,400 | 57,000 |
Full résumé-style profiles: PODD CV · ABBV CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.